Amidst economic challenges in 2009, Finnish pharmaceuticals company Orion showed resilience as its net sales grew to EUR 190mn in the first quarter, marking a EUR 10mn increase from the previous year. This positive performance reflects the company's ability to adapt and thrive in a dynamic market environment.